Skip to main content
ImmuneCited

Quantification of anthocyanins in elderberry and chokeberry dietary supplements.

Christian Vlachojannis, Benno F Zimmermann, Sigrun Chrubasik-Hausmann
Other Phytotherapy research : PTR 2015 37 次引用
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D25597779'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

研究类型
Other
研究人群
men
干预措施
Quantification of anthocyanins in elderberry and chokeberry dietary supplements. 110 mg
对照组
None
主要结局
None
效应方向
Positive
偏倚风险
Unclear

Abstract

Elderberry and chokeberry food supplements may be 'functional food' in patients with metabolic syndrome or influenza but, for this, adequate amounts of co-active ingredients must be consumed in the daily dose. This study aimed to quantify the anthocyanin content in three elderberry and six chokeberry products to assess their usefulness as functional food. Analyses were carried out using an established HPLC procedure. The minimum anthocyanin doses for the treatment of metabolic syndrome disorders were estimated as 110 mg per day and 3.5 g per day for influenza. Three products were inappropriate for clinical use. The lowest liquid supplies were achieved with a proprietary elderberry concentrate (11 mL) and a proprietary chokeberry mother juice (100 mL). Clinical studies are now required to prove the effectiveness and adapt the doses according to the clinical symptoms.

简要概述

The anthocyanin content in three elderberry and six chokeberry products was quantified to assess their usefulness as functional food and clinical studies are now required to prove the effectiveness and adapt the doses according to the clinical symptoms.

Used In Evidence Reviews

Similar Papers